Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACH7 TECHNOLOGIES LIMITED Capital/Financing Update 2017

Nov 12, 2017

65285_rns_2017-11-12_1efc8d59-f1c1-4ea3-87b1-c788537a18ab.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ASX Announcement

13 November 2017

==> picture [610 x 89] intentionally omitted <==

MACH7 BRINGS ONBOARD NEW INSTITUTIONAL INVESTOR

Melbourne, Australia; 13 November 2017: Mach7 Technologies Limited ( Mach7 or the Company ) (ASX:M7T) today announced that it has successfully raised $2 million via an equity placement to Oceania Capital Partners Limited ( OCP ).

Under the placement, Mach7 will issue a total of 11,428,541 ordinary shares to OCP, at an issue price of 17.5 cents per share, raising $2 million of new funding. These new funds will be used for investment into direct sales resources in the U.S., marketing, and new product development – all of which will allow the Company to accelerate its plans for growth. The price per share is equal to the 30-day volume weighted average price (VWAP) (up to and including 9 November) of the Company’s shares with no discount applied. Importantly, the transaction will not attract any broker fees. Settlement of the placement is planned for 14 November 2017.

Robert Moran, Chairman of Oceania Capital said: “We are pleased to support Mach7 with their capital requirements as we believe they have the keys to success: an excellent product which will satisfy an unmet customer requirement in the international health I.T. and data management market; and a very capable and motivated management team.”

Mike Jackman, Mach7 CEO commented: “Our partnership with Oceania Capital is an important step to building a sustainable long term growth business. This new capital investment will help us accelerate our commercial strategies and capture the emerging healthcare data services market opportunity.”

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) develops innovative enterprise imaging IT solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s award-winning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their best-of-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimized vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit www.mach7t.com.

For more information, contact :

Mike Jackman Jenni Pilcher CEO CFO +1 802 391 8229 (U.S.) +61 3 9286 7500 (Australia) [email protected] [email protected]

==> picture [612 x 123] intentionally omitted <==